Kettering Health Network (
Kettering Health Network Logo
Kettering Health Network Logo
Follow FaceBook Follow YouTube Follow Twitter Follow LinkedIn Share

 Latest Additions

Neurosurgeons lace up their athletic shoes to support the American Brain Tumor Association

June 09, 2015

Neurosurgeons Richard Gorman, DO and Phillip Porcelli, DO, are lacing up their athletic shoes to support the American Brain Tumor Association. Both neurosurgeons and other members of The Neuroscience Institute at Kettering Health Network will be participating in the Brain Tumor 5K on Saturday, June 13 in Columbus.

The American Brain Tumor Association is a national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups.

“I am walking for my patients with brain tumors who are fighting for their lives every day,” says Dr. Porcelli. “I hope my walking in this event can improve the quality of life for my patients and all people with brain tumors.”

For more information about the Brain Tumor 5K, visit, click on Join an Event, then under Get Involved click on Breakthrough for Brain Tumors 5K Run & Walk.

The Neuroscience Institute is Kettering Health Network's comprehensive treatment center for diseases and disorders of the brain and spine. The Institute offers the most advanced diagnostic, surgical and therapeutic neuroscience care available. The institute is home to many of the world's most brilliant minds in the field of neuroscience, and the most sophisticated tools and technology, including the NeuroBlate® laser therapy used for patients who have difficult-to-access tumors.

Kettering Health Network also offers a unique nuclear medicine program that helps patients to receive early, more precise diagnoses and improved outcomes using state-of-the-art diagnostic positron emission tomography (PET) imaging. Kettering Medical Center is unique in that it owns a medical cyclotron used to manufacture PET tracers. The hospital is one of only ten medical facilities in the United States that manufactures and uses novel PET tracers (radioactive chemicals not normally offered in hospitals) for direct clinical use. One of these novel tracers is methionine, an amino acid used to diagnose low-grade tumors.

Related News

Category: Neurology